NEWS TIPS & FEATURES

Has Your Treatment Been Denied or Delayed by Your Insurance Company? Read This

There are things you can do if your health plan won’t pay for your medical treatment or delays your care. Learn more here or at at www.CoverageRights.org. You can also join the conversation in the... [...]


Online Community Provides Support for Cancer Patients and Caregivers

The rise of social media in cancer care has coincided with a movement in which patients are becoming more active in healthcare decisions and seeking more-personalized care—educating themselves about... [...]


ASCO Recommends Early Integration of Palliative Care for Advanced Cancers

The American Society of Clinical Oncology (ASCO) has updated its guidelines on the integration of palliative care for patients diagnosed with advanced cancer, as well as their caretakers. In essence, the... [...]


Cabometyx™ Improves Time to Cancer Progression as Initial Therapy in Kidney Cancer

The agent Cabometyx™ (cabozantinib) improves anti-cancer responses and time to cancer progression compared to Sutent® (sunitinib) when used as initial therapy for advanced kidney cancer. These results... [...]


Personalized Medicine: Access Is Power

Personalized medicine has the potential to save women’s lives, but not if they can’t access it. By Stacey L. Worthy, Esq. One of the most exciting advances in health­care is the growing field of personal­ized... [...]


Duration of Blood Storage Does Not Affect Outcomes for Patients Requiring Blood Transfusions

The length of time that blood is stored prior to a blood transfusion, within normal ranges, does not appear to affect mortality among patients requiring transfusions. These results were recently published... [...]


fm78

Unmasking the Genetics of Early Heart Disease

Catching familial hypercholesterolemia early can save lives  By Heather Stringer Katherine Wilemon was 15 when she discovered that she was living with extremely high cholesterol levels in her blood. At... [...]


Opdivo® Improves Survival in Advanced Stomach Cancer

The immune-stimulating agent Opdivo® (nivolumab) appears to significantly improve overall survival among patients with advanced stomach cancer for which no standard treatment options exist. Opdivo is... [...]


Darzalex® Approved for Additional Indications in Multiple Myeloma

The United States Food and Drug Administration (FDA) has approved Darzalex® (daratumumab) for the treatment of multiple myeloma among patients who have received at least one prior therapy. The new FDA... [...]


« More News Tips & Features

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS